Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
about
The advancement of multidimensional QSAR for novel drug discovery - where are we headed?Computational evidence for intramolecular hydrogen bonding and nonbonding X···O interactions in 2'-haloflavonols.Synthesis, docking study and β-adrenoceptor activity of some new oxime ether derivatives.The MIA-QSAR Method for the Prediction of Bioactivities of Possible Acetylcholinesterase InhibitorsRational design of small modified peptides as ACE inhibitorsMolecular modelling ofMycobacterium tuberculosisacetolactate synthase catalytic subunit and its molecular docking study with inhibitors
P2860
Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Novel anti-HIV cyclotriazadisu ...... and receptor-based approaches.
@en
Novel anti-HIV cyclotriazadisu ...... and receptor-based approaches.
@nl
type
label
Novel anti-HIV cyclotriazadisu ...... and receptor-based approaches.
@en
Novel anti-HIV cyclotriazadisu ...... and receptor-based approaches.
@nl
prefLabel
Novel anti-HIV cyclotriazadisu ...... and receptor-based approaches.
@en
Novel anti-HIV cyclotriazadisu ...... and receptor-based approaches.
@nl
P2093
P1476
Novel anti-HIV cyclotriazadisu ...... and receptor-based approaches.
@en
P2093
Elaine F F da Cunha
Júlia R Pinheiro
Michelle Bitencourt
Teodorico C Ramalho
P304
P356
10.1016/J.BMC.2007.11.020
P407
P577
2007-11-13T00:00:00Z